4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000899243-21-031793
Chief Commercial Officer sold 25,000 shares at $21.18 ($529,420)
- Chief Commercial Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Maduck Sean Chief Commercial Officer | 2021-08-03 | Option exercise | +25,000 | $3.29 | $82,250 | 65,024 | D: show line 1 in the form |
| Maduck Sean Chief Commercial Officer | 2021-08-03 | Sale | −25,000 | $21.18 | $529,420 | 40,024 | D: show line 2 in the form |
| Open-market sales · 25,000 sh · avg $21.18 · $529,420 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Maduck Sean Chief Commercial Officer | 2021-08-03 | Option exercise · Stock Option (Right to Buy) | −25,000 | 172,602 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…